At present, the studies regarding ALKBH5, FTO genes were mainly focused on cancer, and ALKBH5, FTO had been identified as important malignant regulators of tumor cell phenotypes and therapeutic responses (Lan et al., 2020; Zhang et al., 2021). This evidence concerns the gene FTO and neoplasm.